Achilles Pain Clinical Trial
Official title:
Radiofrequency-based Plasma Microdebridement Compared to Surgical Microdebridement for Treating Achilles Tendinosis: A Prospective, Randomized, Controlled Multi-Center Study"
Verified date | July 2013 |
Source | ArthroCare Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This is a research study to evaluate the outcomes after the study procedure for pain and
discomfort in the heel caused from an injury in the Achilles tendon which is located on the
back of the foot (commonly called "Achilles tendinitis"-Achilles tendinosis) that has not
gotten better with medicine and/or other therapy.
Researchers want to see if using the study device changes outcomes for 1 year after the
study procedure.
Status | Completed |
Enrollment | 60 |
Est. completion date | September 2010 |
Est. primary completion date | July 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Subject is at least 18 years of age - Subject presents with pain associated with the Achilles tendon graded as >5 on a 0 to 10- point scale - Subject's history and physical examination pinpoints anatomic origin of Achilles pain as associated with degeneration of the Achilles (non-insertional - proximal to retrocalcaneal bursa) - Magnetic resonance imaging findings consistent with tendinosis - Subject (or guardian) must sign IRB approved informed consent form - Subject is willing and able to complete required follow-up Exclusion Criteria: - Use of NSAID's (e.g., ibuprofen, naproxen) within 2 weeks prior to treatment by this study - Previous Achilles surgery on pathology to be treated by this study - Heel pain associated with plantar fasciosis - Multiple anatomic origins of pain in foot to be treated by study - History or documentation showing Type I and Type II Diabetes Mellitus - Physical findings and documentation of coagulopathy, infection, tumor or other systemic disease(s) - History or documentation showing peripheral vascular disease or autoimmune disease - Subject is currently participating in another drug/device study related to the degenerated Achilles - Pregnant or pregnant suspected subjects prior to treatment - History of Extracorporeal Shock Wave Treatment (ESWT) on foot to be treated by study - Subject is incapable of understanding or responding to the study questionnaires |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Greater Chesapeake Orthopaedic Associates | Baltimore | Maryland |
United States | Orthopaedic Foot and Ankle Center | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
ArthroCare Corporation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To determine whether patients treated using plasma microtenotomy demonstrate equivalent longitudinal improvement of AOFAS Ankle-Hindfoot Scale scores through 12 months postoperatively to patients treated using standard surgical debridement. | 12 months | No | |
Secondary | To determine whether recovery from postoperative pain, quality of life and clinical events are equivalent for treatment groups. | 12 Months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03274557 -
Radiofrequence Microtenotomy for Treatment of Achilles Tendinose
|
N/A |